# MTERF2

## Overview
MTERF2, or mitochondrial transcription termination factor 2, is a gene that encodes a protein involved in the regulation of mitochondrial gene expression. The MTERF2 protein is categorized as a transcription factor and is primarily localized within the mitochondrial matrix, where it plays a critical role in the transcriptional regulation of mitochondrial DNA (mtDNA). It is known to bind non-specifically across mtDNA, suggesting a regulatory function in mitochondrial replication and transcription processes (Huang2011Mitochondrial). MTERF2 acts as a negative regulator of mitochondrial gene expression, influencing the assembly of the oxidative phosphorylation (OXPHOS) complex and, consequently, ATP production (Huang2011Mitochondrial). The protein's interactions with other mitochondrial transcription termination factors and its oligomerization potential further underscore its significance in mitochondrial function and energy homeostasis (Roberti2010MTERF; Wenz2009RETRACTED:). Alterations in MTERF2 expression have been associated with various clinical conditions, including cancer and neurodegenerative diseases, highlighting its potential as a prognostic biomarker and therapeutic target (Han2016MTERF2; Sun2019Prognostic).

## Function
MTERF2 (mitochondrial transcription termination factor 2) is a protein that plays a crucial role in the regulation of mitochondrial gene expression. It is primarily localized in the mitochondrial matrix, where it binds to mitochondrial DNA (mtDNA) and is involved in the transcription regulation of mitochondrial genes. MTERF2 has been shown to bind non-specifically across the entire mtDNA, suggesting a role in regulating the replication process rather than the initiation of mtDNA replication (Huang2011Mitochondrial).

In healthy human cells, MTERF2 acts as a negative regulator of mitochondrial gene expression. Overexpression of MTERF2 in HeLa cells leads to a significant decrease in mtDNA content, as well as reduced levels of mitochondrial mRNA and proteins, which suggests that MTERF2 may inhibit cell growth by reducing the assembly of the oxidative phosphorylation (OXPHOS) complex, leading to insufficient ATP production (Huang2011Mitochondrial). This regulatory function is crucial for maintaining proper mitochondrial function and energy production within the cell.

MTERF2 is also involved in the coordination of mitochondrial transcription, which is essential for the production and assembly of respiratory complex subunits. This coordination requires the expression of both nuclear and mitochondrial genomes, with MTERF2 contributing to the regulation of these processes (Roberti2010MTERF).

## Clinical Significance
Alterations in the expression of the MTERF2 gene have been linked to various diseases and conditions. In non-small cell lung cancer (NSCLC), particularly lung adenocarcinoma (LUAD), high MTERF2 mRNA expression is associated with improved overall survival rates, suggesting its potential as a prognostic biomarker. Conversely, low MTERF2 expression in early-stage NSCLC is linked to poorer survival outcomes, indicating its clinical significance in cancer prognosis (Sun2019Prognostic).

In the context of neurodegenerative disorders, MTERF2 has been implicated in Parkinson's disease (PD). Studies have shown that MTERF2 expression increases in response to MPP+ treatment, a model for PD, leading to mitochondrial dysfunction and cell damage. Knockdown of MTERF2 alleviates these effects, suggesting that MTERF2 contributes to mitochondrial disruption and cell damage in PD, making it a potential therapeutic target (Han2016MTERF2).

MTERF2's role in mitochondrial function is further highlighted by its involvement in oxidative phosphorylation (OXPHOS). Disruption of MTERF2 in mice leads to decreased levels of OXPHOS proteins and impaired respiratory function, which are associated with myopathy and memory deficits (Peralta2012Mitochondrial; Wenz2009RETRACTED:). These findings underscore the importance of MTERF2 in maintaining mitochondrial integrity and its potential impact on various diseases.

## Interactions
MTERF2 is known to interact with mitochondrial DNA (mtDNA) and other mitochondrial transcription termination factors, playing a role in regulating mitochondrial transcription. It specifically binds to the heavy strand promoter (HSP) region of mtDNA, which suggests its involvement in transcription regulation (Roberti2010MTERF; Wenz2009RETRACTED:). MTERF2 has been shown to coimmunoprecipitate with other mTERF family members, such as mTERF1 and mTERF3, indicating potential interactions among these proteins. These interactions are likely mediated by mtDNA, as the presence of mtDNA is necessary for the interaction between mTERF2 and mTERF3 (Wenz2009RETRACTED:).

MTERF2 also exhibits oligomerization potential, forming dimers in vivo and in vitro. This is supported by the presence of conserved leucine zipper domains, which facilitate protein-protein interactions, and the structural presence of coiled-coil domains in MTERF2 (Wenz2009RETRACTED:). These interactions suggest that MTERF2, along with mTERF1 and mTERF3, may form a complex at the HSP region to regulate mitochondrial transcription (Wenz2009RETRACTED:). Additionally, MTERF2's binding to the entire mtDNA implies a broader regulatory role in mitochondrial gene expression (Huang2011Mitochondrial).


## References


[1. (Roberti2010MTERF) Marina Roberti, Paola Loguercio Polosa, Francesco Bruni, Stefania Deceglie, Maria Nicola Gadaleta, and Palmiro Cantatore. Mterf factors: a multifunction protein family. BioMolecular Concepts, 1(2):215–224, August 2010. URL: http://dx.doi.org/10.1515/bmc.2010.015, doi:10.1515/bmc.2010.015. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1515/bmc.2010.015)

[2. (Wenz2009RETRACTED:) Tina Wenz, Corneliu Luca, Alessandra Torraco, and Carlos T. Moraes. Retracted: mterf2 regulates oxidative phosphorylation by modulating mtdna transcription. Cell Metabolism, 9(6):499–511, June 2009. URL: http://dx.doi.org/10.1016/j.cmet.2009.04.010, doi:10.1016/j.cmet.2009.04.010. This article has 76 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cmet.2009.04.010)

[3. (Peralta2012Mitochondrial) Susana Peralta, Xiao Wang, and Carlos T. Moraes. Mitochondrial transcription: lessons from mouse models. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 1819(9–10):961–969, September 2012. URL: http://dx.doi.org/10.1016/j.bbagrm.2011.11.001, doi:10.1016/j.bbagrm.2011.11.001. This article has 38 citations.](https://doi.org/10.1016/j.bbagrm.2011.11.001)

[4. (Huang2011Mitochondrial) Weiwei Huang, Min Yu, Yang Jiao, Jie Ma, Mingxing Ma, Zehua Wang, Hong Wu, and Deyong Tan. Mitochondrial transcription termination factor 2 binds to entire mitochondrial dna and negatively regulates mitochondrial gene expression. Acta Biochimica et Biophysica Sinica, 43(6):472–479, June 2011. URL: http://dx.doi.org/10.1093/abbs/gmr035, doi:10.1093/abbs/gmr035. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/abbs/gmr035)

[5. (Sun2019Prognostic) Shuangyan Sun, Chunjiao Wu, Changliang Yang, Jian Chen, Xiu Wang, Yingji Nan, Zhicheng Huang, and Lixia Ma. Prognostic roles of mitochondrial transcription termination factors in non‑small cell lung cancer. Oncology Letters, July 2019. URL: http://dx.doi.org/10.3892/ol.2019.10680, doi:10.3892/ol.2019.10680. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2019.10680)

[6. (Han2016MTERF2) Yanyan Han, Peiye Gao, Shi Qiu, Linbing Zhang, Ling Yang, Ji Zuo, Chunjiu Zhong, Shun Zhu, and Wen Liu. Mterf2 contributes to mpp+-induced mitochondrial dysfunction and cell damage. Biochemical and Biophysical Research Communications, 471(1):177–183, February 2016. URL: http://dx.doi.org/10.1016/j.bbrc.2016.01.156, doi:10.1016/j.bbrc.2016.01.156. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2016.01.156)